XNCR Q2 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+415.3% YoY

Gross Profit

$18M26.6% margin

Operating Income

$9M13.5% margin

Net Income

$52M77.5% margin

EPS (Diluted)

$0.87

QoQ Revenue Growth

+98.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$696M

Total Liabilities

$49M

Stockholders' Equity

$647M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$13M	+415.3%
Gross Profit	$18M	-$30M	+159.1%
Operating Income	$9M	-$38M	+124.2%
Net Income	$52M	-$35M	+249.2%

Revenue Segments

Collaboration

$59M87%

Royalty

$7M11%

Milestone

$2M2%